Cargando…
Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers
Epidermal growth factor receptor (EGFR) gene mutations and increased copy numbers are considered as predictors of response to EGFR tyrosine kinase inhibitors (EGFR-TKI) in non-small-cell lung cancer (NSCLC). Lung cancer diagnosis is often based on cytology alone. However, almost all published data o...
Autores principales: | Savic, S, Tapia, C, Grilli, B, Rufle, A, Bihl, M P, de Vito Barascud, A, Herzog, M, Terracciano, L, Baty, F, Bubendorf, L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359717/ https://www.ncbi.nlm.nih.gov/pubmed/18087280 http://dx.doi.org/10.1038/sj.bjc.6604142 |
Ejemplares similares
-
Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer
por: Cihoric, N, et al.
Publicado: (2014) -
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
por: Went, P, et al.
Publicado: (2006) -
CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer
por: Lugli, A, et al.
Publicado: (2009) -
Novel heteroduplex method using small cytology specimens with a remarkably high success rate for analysing EGFR gene mutations with a significant correlation to gefitinib efficacy in non-small-cell lung cancer
por: Oshita, F, et al.
Publicado: (2006) -
HER2 gene status in primary breast cancers and matched distant metastases
por: Tapia, Coya, et al.
Publicado: (2007)